Cargando…
Farnesoid X receptor antagonizes Wnt/β-catenin signaling in colorectal tumorigenesis
Farnesoid X receptor (FXR, encoded by NR1H4), a critical regulator of bile acid homeostasis, is widely implicated in human tumorigenesis. However, the functional role of FXR in colorectal cancer (CRC) and the precise molecular mechanism remain unclear. In this study, we demonstrated that FXR express...
Autores principales: | Yu, Junhui, Li, Shan, Guo, Jing, Xu, Zhengshui, Zheng, Jianbao, Sun, Xuejun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431544/ https://www.ncbi.nlm.nih.gov/pubmed/32807788 http://dx.doi.org/10.1038/s41419-020-02819-w |
Ejemplares similares
-
Farnesoid X receptor activation induces antitumour activity in colorectal cancer by suppressing JAK2/STAT3 signalling via transactivation of SOCS3 gene
por: Li, Shan, et al.
Publicado: (2020) -
Multilevel regulation of Wnt signaling by Zic2 in colon cancer due to mutation of β-catenin
por: Xu, Zhengshui, et al.
Publicado: (2021) -
CDX2 inhibits epithelial–mesenchymal transition in colorectal cancer by modulation of Snail expression and β-catenin stabilisation via transactivation of PTEN expression
por: Yu, Junhui, et al.
Publicado: (2020) -
Effects and mechanism of the bile acid (farnesoid X) receptor on the Wnt/β-catenin signaling pathway in colon cancer
por: Mao, Jiayu, et al.
Publicado: (2020) -
Synergistic tumor inhibition of colon cancer cells by nitazoxanide and obeticholic acid, a farnesoid X receptor ligand
por: Yu, Junhui, et al.
Publicado: (2020)